Digest Network How does it work
Network
/
Society
Bo
Not verified

Boehringer Ingelheim

What we write about

Advertising / Marketing / Media / CommunicatiImpreseIndustriaMedical Health WellnessPharmaceuticals

12 Press releases

View all press releases
Press Release cover image
22/11/2024
Pharmaceuticals
Sanità
Economics
Start-up
Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs
Source
Boehringer Ingelheim
Issuer
PR News Wire
1.00
0
07/10/2024
Pharmaceuticals
Medical Health Wellness
Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide
Source
Boehringer Ingelheim
Issuer
GLOBENEWSWIRE
1.00
0
27/09/2024
Pharmaceuticals
Medical Health Wellness
Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities
Source
Boehringer Ingelheim
Issuer
GLOBENEWSWIRE
1.00
0
25/09/2024
Pharmaceuticals
Medical Health Wellness
Boehringer Ingelheim expands cancer research at its Vienna site
Source
Boehringer Ingelheim
Issuer
GLOBENEWSWIRE
1.00
0
16/09/2024
Pharmaceuticals
Medical Health Wellness
Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
Source
Boehringer Ingelheim
Issuer
GLOBENEWSWIRE
1.00
0
09/09/2024
Pharmaceuticals
Medical Health Wellness
Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients
Source
Boehringer Ingelheim
Issuer
GLOBENEWSWIRE
1.00
0
05/09/2024
Pharmaceuticals
Medical Health Wellness
Boehringer Ingelheim announces plans to advance potential new treatment for Geographic Atrophy, following positive Phase I results
Source
Boehringer Ingelheim
Issuer
GLOBENEWSWIRE
1.00
0
03/09/2024
Pharmaceuticals
Advertising / Marketing / Media / Communicati
Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio
Source
Boehringer Ingelheim
Issuer
GLOBENEWSWIRE
1.00
0
28/07/2024
Pharmaceuticals
Medical Health Wellness
CHMP adopts positive opinion recommending approval of new and expanded indications for SPEVIGO®
Source
Boehringer Ingelheim
Issuer
GLOBENEWSWIRE
1.00
0
18/07/2024
Pharmaceuticals
Medical Health Wellness
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
Source
Boehringer Ingelheim
Issuer
GLOBENEWSWIRE
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0